Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Solid Malignancies, Non-Hodgkin's Lymphoma
About this trial
This is an interventional treatment trial for Solid Malignancies focused on measuring diffuse, follicular, chronic lymphocytic leukemia, colorectal cancer, pancreatic cancer, acute myelogenous leukemia, head and neck cancer, breast cancer, prostate cancer, ovarian cancer, bladder cancer, hypoxia, refractory, metastatic
Eligibility Criteria
Inclusion Criteria: Advanced solid malignancy or non-Hodgkin's lymphoma that is refractory to treatment or has recurred Age > 18 years Adequate hematologic (blood), kidney and liver function Negative pregnancy test (females of childbearing potential only) Willingness to use effective contraception by both males and females throughout the treatment period and for at least 2 months following treatment. Exclusion Criteria: Any chemotherapy or radiation within the past 4 weeks Symptomatic or uncontrolled brain metastases (patients with history of brain metastases who have had repeat brain scans within the past 30 days that demonstrate no evidence of tumor progression or brain swelling and who do not require corticosteriod treatment may be eligible) Significant cardiovascular illness including, but not limited to, the following: active infection, uncontrolled hypertension, symptomatic congestive heart failure, unstable angina pectoris, heart attack within the past six months, or uncontrolled, irregular heart beat Inadequate cardiac function Prior investigational therapy within the past 28 days Pregnant or breast feeding women
Sites / Locations
- Weiler Hospital of Albert Einstein College of Medicine
- Cancer Therapy & Research Center / Institute for Drug Development